Welcome

NanoIVD Inc. researches, develops, and commercializes blood-based tests for early cancer screening, cancer-recurrence monitoring, treatment-effectiveness monitoring, and personalized molecular cancer profiling for therapeutic selection. It owns an algorithm for cancer biomarker selection and proprietary nanowire field-effect-transistor (NW-FET) chip technology for label-free, real-time in-vitro diagnostic (IVD) testing.